Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC15714936;4937;4938 chr2:178777252;178777251;178777250chr2:179641979;179641978;179641977
N2AB15714936;4937;4938 chr2:178777252;178777251;178777250chr2:179641979;179641978;179641977
N2A15714936;4937;4938 chr2:178777252;178777251;178777250chr2:179641979;179641978;179641977
N2B15254798;4799;4800 chr2:178777252;178777251;178777250chr2:179641979;179641978;179641977
Novex-115254798;4799;4800 chr2:178777252;178777251;178777250chr2:179641979;179641978;179641977
Novex-215254798;4799;4800 chr2:178777252;178777251;178777250chr2:179641979;179641978;179641977
Novex-315714936;4937;4938 chr2:178777252;178777251;178777250chr2:179641979;179641978;179641977

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCC
  • RefSeq wild type template codon: AGG
  • Domain: Ig-7
  • Domain position: 16
  • Structural Position: 25
  • Q(SASA): 0.1655
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/F None None 0.002 N 0.333 0.2 0.275641507738 gnomAD-4.0.0 6.84106E-07 None None None None N None 0 0 None 0 0 None 0 0 8.99316E-07 0 0
S/Y None None 0.272 N 0.472 0.194 0.292423486923 gnomAD-4.0.0 1.36821E-06 None None None None N None 0 0 None 0 0 None 0 0 1.79863E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0805 likely_benign 0.0798 benign -0.548 Destabilizing None N 0.113 neutral N 0.451978099 None None N
S/C 0.117 likely_benign 0.1089 benign -0.32 Destabilizing 0.851 D 0.457 neutral D 0.546956627 None None N
S/D 0.3835 ambiguous 0.3687 ambiguous 0.392 Stabilizing 0.001 N 0.21 neutral None None None None N
S/E 0.4613 ambiguous 0.4332 ambiguous 0.31 Stabilizing 0.124 N 0.39 neutral None None None None N
S/F 0.1921 likely_benign 0.1977 benign -1.139 Destabilizing 0.002 N 0.333 neutral N 0.442028152 None None N
S/G 0.1072 likely_benign 0.1074 benign -0.663 Destabilizing 0.055 N 0.399 neutral None None None None N
S/H 0.3596 ambiguous 0.339 benign -1.227 Destabilizing 0.859 D 0.465 neutral None None None None N
S/I 0.2396 likely_benign 0.2374 benign -0.372 Destabilizing 0.124 N 0.449 neutral None None None None N
S/K 0.6502 likely_pathogenic 0.6156 pathogenic -0.324 Destabilizing 0.22 N 0.415 neutral None None None None N
S/L 0.1076 likely_benign 0.1116 benign -0.372 Destabilizing 0.055 N 0.435 neutral None None None None N
S/M 0.1747 likely_benign 0.1742 benign -0.031 Destabilizing 0.667 D 0.465 neutral None None None None N
S/N 0.1473 likely_benign 0.1449 benign -0.083 Destabilizing 0.124 N 0.419 neutral None None None None N
S/P 0.8943 likely_pathogenic 0.9024 pathogenic -0.403 Destabilizing 0.301 N 0.471 neutral D 0.545290546 None None N
S/Q 0.4509 ambiguous 0.4232 ambiguous -0.349 Destabilizing 0.667 D 0.477 neutral None None None None N
S/R 0.5879 likely_pathogenic 0.5569 ambiguous -0.198 Destabilizing 0.497 N 0.469 neutral None None None None N
S/T 0.0831 likely_benign 0.0822 benign -0.246 Destabilizing 0.001 N 0.139 neutral N 0.453085965 None None N
S/V 0.1915 likely_benign 0.1907 benign -0.403 Destabilizing 0.124 N 0.44 neutral None None None None N
S/W 0.3699 ambiguous 0.3599 ambiguous -1.084 Destabilizing 0.958 D 0.507 neutral None None None None N
S/Y 0.1839 likely_benign 0.184 benign -0.812 Destabilizing 0.272 N 0.472 neutral N 0.455918479 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.